How is the Edgewise Therapeutics Inc today?

The Edgewise Therapeutics Inc today is trading in the down by -1.99% at 14.28.

How has Edgewise Therapeutics Inc performed historically?

The Edgewise Therapeutics Inc is currently trading down -1.99% on an intraday basis in the past week the index rose 0.49%. The index has been down -45.43% in the past quarter and fell -16.64% in the past year. You can view this in the overview section.

What is Edgewise Therapeutics Inc Annual Net Profit?

Edgewise Therapeutics Inc Annual Net Profit fell 33.6% in the last year to $133.81 M. Its sector's average net profit growth for the last fiscal year was -11.09%.

What is Edgewise Therapeutics Inc Price to Earning Ratio?

Edgewise Therapeutics Inc Price to Earning Ratio is -10.28, which is negative.

What is Edgewise Therapeutics Inc Stock Price?

Edgewise Therapeutics Inc Stock Price fell 16.64% and underperformed its sector by 72.11% in the past year.

What is Edgewise Therapeutics Inc Quarterly Net profit?

Edgewise Therapeutics Inc Quarterly Net profit fell 43.03% YoY to $40.8 M. Its sector's average net profit growth YoY for the quarter was -212.88%.

What is Edgewise Therapeutics Inc Debt to Equity Ratio?

Edgewise Therapeutics Inc Debt to Equity Ratio of 0.01 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Edgewise Therapeutics Inc Return on Equity(ROE)?

Edgewise Therapeutics Inc Return on Equity(ROE) for the last financial year was -34.4%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Edgewise Therapeutics Inc Mutual Fund Holding?

Edgewise Therapeutics Inc Mutual Fund Holding decreased by 2.39% in the last quarter to 31.99.

What is Edgewise Therapeutics Inc Institutional Holding?

Edgewise Therapeutics Inc Institutional Holding increased by 7.47% in the last quarter to 100.77.

Edgewise Therapeutics Inc XNAS: EWTX

Edgewise Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Name: Edgewise Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Edgewise Therapeutics Inc
Rating: 0.90416675
Author: Trendlyne DVM scores

about

Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapie...

14.28 -0.29 (-1.99%)

62.54% Fall from 52W High

898.7K XNAS Volume

XNAS 30 May, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for Edgewise Therapeutics Inc is on 06 Jun 2025 for the purpose of Edgewise Therapeutics Inc Annual General Meeting for 2024 See details

Not Eligible

Expensive Valuation

5.7 / 100

Technically Bearish

30.5 / 100

No estimates available

Edgewise Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Edgewise Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapie...

62.54% Fall from 52W High

SWOT Analysis

Edgewise Therapeutics Inc Live Price Chart

Edgewise Therapeutics Inc FAQ

How is Edgewise Therapeutics Inc today?

Edgewise Therapeutics Inc today is trading in the red, and is down by -1.99% at 14.28.

How has Edgewise Therapeutics Inc performed historically?

Edgewise Therapeutics Inc is currently trading down -1.99% on an intraday basis. In the past week the stock rose 0.49%. stock has been down -45.43% in the past quarter and fell -16.64% in the past year. You can view this in the overview section.